Nyxoah SA Form 6-K Summary
Business Context and Reporting Period
Nyxoah SA, a Belgian medical technology company, furnished this Form 6-K for May 2022. The filing was signed and dated May 6, 2022, and relates to corporate governance and shareholder meeting matters rather than operating or financial results.
Key Financial Metrics
The filing does not provide revenue, profit or loss, cash flow, margins, debt, liquidity, guidance, or other financial metrics.
Material Changes and Corporate Actions
- The Company announced that its annual shareholders’ meeting would be held on June 8, 2022, at 2:00 p.m. CET.
- An extraordinary shareholders’ meeting would follow immediately after the annual meeting.
- Raymond Cohen and Virginia Kirby were nominated for appointment to the Company’s board of directors.
Outlook, Risks, and Unusual Items
The filing contains no management outlook, financial guidance, risk updates, contingencies, or unusual financial items. Exhibits 99.1 and 99.2 contain the related May 6, 2022 press releases and were furnished, not filed, for purposes of Section 18 of the Exchange Act.
Investor Verification Items
- Verify the final agendas, resolutions, and voting outcomes of the June 8 annual and extraordinary shareholders’ meetings.
- Verify whether Raymond Cohen and Virginia Kirby were appointed to the board and review their relevant qualifications.
- Review the attached press releases for additional meeting or governance details not reproduced in the filing text.
- Do not interpret this Form 6-K as a financial-results or operating-update filing.